Published in Diabetes Care on August 01, 1995
Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest (2004) 1.92
Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation. Exp Neurol (2011) 1.65
Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect (1998) 1.56
Oxidative stress: key player in gastrointestinal complications of diabetes. Neurogastroenterol Motil (2011) 1.25
Early diabetic neuropathy: triggers and mechanisms. World J Gastroenterol (2007) 1.06
Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis (2008) 1.06
Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes. Int J Mol Med (2007) 1.05
Diabetes and alpha lipoic Acid. Front Pharmacol (2011) 1.01
Alpha-lipoic Acid and diabetic neuropathy. Rev Diabet Stud (2009) 1.00
Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol (2012) 1.00
PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function. Free Radic Biol Med (2011) 0.99
Diabetic neuropathy part 1: overview and symmetric phenotypes. Neurol Clin (2013) 0.99
Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies. Am J Pathol (2010) 0.97
Advanced Diabetic Neuropathy: A Point of no Return? Rev Diabet Stud (2006) 0.94
Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med Genet (2001) 0.94
Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress. Free Radic Biol Med (2012) 0.93
Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies. Free Radic Biol Med (2010) 0.93
Mechanisms of chemotherapy-induced behavioral toxicities. Front Neurosci (2015) 0.92
The spectrum of diabetic neuropathies. Phys Med Rehabil Clin N Am (2008) 0.92
Endoplasmic reticulum stress plays a key role in the pathogenesis of diabetic peripheral neuropathy. Diabetes (2013) 0.91
Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice. Rheumatol Int (2006) 0.88
Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathy. Biochem Pharmacol (2012) 0.88
Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy. Ther Clin Risk Manag (2011) 0.87
Effect of inhibition of glutathione synthesis on insulin action: in vivo and in vitro studies using buthionine sulfoximine. Biochem J (2000) 0.86
Lipid lowering effect of antioxidant alpha-lipoic Acid in experimental atherosclerosis. J Clin Biochem Nutr (2008) 0.86
Efficacy of alpha-lipoic acid against diabetic cataract in rat. Jpn J Ophthalmol (2007) 0.85
Management options for established chemotherapy-induced peripheral neuropathy. Support Care Cancer (2014) 0.84
Antioxidant strategies in the management of diabetic neuropathy. Biomed Res Int (2015) 0.83
Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats. Diabetes (2012) 0.83
Combination therapies prevent the neuropathic, proinflammatory characteristics of bone marrow in streptozotocin-induced diabetic rats. Diabetes (2014) 0.81
Traditional chinese medicine tang-luo-ning ameliorates sciatic nerve injuries in streptozotocin-induced diabetic rats. Evid Based Complement Alternat Med (2013) 0.80
Evaluation of PMI-5011, an ethanolic extract of Artemisia dracunculus L., on peripheral neuropathy in streptozotocin-diabetic mice. Int J Mol Med (2011) 0.79
Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors. Metabolism (2008) 0.78
Effect of telmisartan in experimentally induced diabetetes mellitus in rats. Int J Health Sci (Qassim) (2007) 0.77
12/15-Lipoxygenase inhibition counteracts MAPK phosphorylation in mouse and cell culture models of diabetic peripheral neuropathy. J Diabetes Mellitus (2013) 0.76
NO- and non-NO-, non-prostanoid-dependent vasodilatation in rat sciatic nerve during maturation and developing experimental diabetic neuropathy. J Physiol (2002) 0.76
The effect of ∞-lipoic Acid in blood lipid levels and malondialdehyde in atherosclerotic-induced new zealand white rabbit. Malays J Med Sci (2001) 0.75
Alpha-lipoic acid does not acutely affect resistance and conduit artery function or oxidative stress in healthy men. Br J Clin Pharmacol (2004) 0.75
Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications. Healthcare (Basel) (2017) 0.75
Chronic treatment of (R)-α-lipoic acid reduces blood glucose and lipid levels in high-fat diet and low-dose streptozotocin-induced metabolic syndrome and type 2 diabetes in Sprague-Dawley rats. Pharmacol Res Perspect (2017) 0.75
Pain Improvement With Novel Combination Analgesic Regimens (PAIN-CARE): Randomized Controlled Trial Protocol. JMIR Res Protoc (2017) 0.75
Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential. Inflamm Res (2017) 0.75
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes (2001) 3.83
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med (2000) 3.57
Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med (1991) 3.29
The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology (1999) 3.09
Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology (1993) 2.92
Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol (1983) 2.90
Utility of thermography in the diagnosis of lumbosacral radiculopathy. Neurology (1991) 2.66
Value of autonomic testing in reflex sympathetic dystrophy. Mayo Clin Proc (1995) 2.65
Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology (1995) 2.42
The sympathetic nervous system in diabetic neuropathy. A clinical and pathological study. Brain (1975) 2.20
Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol (1990) 1.92
3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J Med (1989) 1.89
Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc (1989) 1.85
Nonsystemic vasculitic neuropathy. Brain (1987) 1.84
Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry (2003) 1.81
Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol (1982) 1.77
Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure. Ann Neurol (1998) 1.76
Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med (1986) 1.75
Postural tachycardia syndrome: clinical features and follow-up study. Mayo Clin Proc (1999) 1.74
Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain (1984) 1.69
A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (1994) 1.68
Influence of posture on the Valsalva manoeuvre. Clin Sci (Lond) (2001) 1.67
A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology (1998) 1.67
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med (2004) 1.65
Aldehyde-induced protein modifications in human plasma: protection by glutathione and dihydrolipoic acid. J Lab Clin Med (1994) 1.56
The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes (1997) 1.48
Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology (1994) 1.47
Basal forebrain malformation with hyperhidrosis and hypothermia: variant of Shapiro's syndrome. Neurology (2001) 1.46
Autonomic involvement in extrapyramidal and cerebellar disorders. Clin Auton Res (1991) 1.44
Hypocapnia and cerebral hypoperfusion in orthostatic intolerance. Stroke (1998) 1.44
The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology (1991) 1.43
Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes (1997) 1.42
Urine culture transport tubes: effect of sample volume on bacterial toxicity of the preservative. J Clin Microbiol (1982) 1.42
Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol (2001) 1.42
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38
Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation (1997) 1.38
The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology (1992) 1.38
Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure. J Appl Physiol (1985) (1991) 1.36
Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol (1999) 1.35
Autoregulation of cerebral blood flow in orthostatic hypotension. Stroke (1998) 1.35
The role of oxidative stress and NF-kappaB activation in late diabetic complications. Biofactors (1999) 1.33
Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol (1991) 1.31
Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes (1996) 1.30
Baroreflex control of muscle sympathetic nerve activity in postural orthostatic tachycardia syndrome. Am J Physiol Heart Circ Physiol (2005) 1.29
Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract (2001) 1.28
Autonomic dysfunction in dementia with Lewy bodies. Neurology (2004) 1.25
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Embryonic stem cell-like cells derived from adult human testis. Hum Reprod (2009) 1.22
Charcot-Marie-Tooth disease with Leber optic atrophy. Neurology (1978) 1.21
Ischemic conduction failure and energy metabolism in experimental diabetic neuropathy. Am J Physiol (1985) 1.20
Effects of changes of blood pressure, respiratory acidosis and hypoxia on blood flow in the sciatic nerve of the rat. J Physiol (1984) 1.20
The sympathetic nervous system in alcoholic neuropathy. A clinical and pathological study. Brain (1975) 1.20
Evaluation of skin vasomotor reflexes by using laser Doppler velocimetry. Mayo Clin Proc (1983) 1.20
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia (1997) 1.19
Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve (1992) 1.19
Autonomic dysfunction in gastrointestinal motility disorders. Gut (1993) 1.18
Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology (2008) 1.18
Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology (2007) 1.16
Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells. Hum Gene Ther (2011) 1.15
Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care (1998) 1.15
Chronic idiopathic anhidrosis. Ann Neurol (1985) 1.14
Increased endoneurial fluid pressure in experimental lead neuropathy. Nature (1977) 1.14
Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Am J Physiol (1986) 1.13
Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy. Neurology (2009) 1.12
Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology (2004) 1.12
Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc (1982) 1.12
Acute panautonomic neuropathy. Ann Neurol (1983) 1.11
Vasovagal syncope. Ann Intern Med (2000) 1.11
Lack of global vagal propensity in patients with oculocardiac reflex. Ophthalmology (1994) 1.11
Permanent axotomy, a model of axonal atrophy and secondary segmental demyelination and remyelination. Ann Neurol (1981) 1.11
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci (2001) 1.10
Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve (2009) 1.09
Normative data on phases of the Valsalva maneuver. J Clin Neurophysiol (1998) 1.08
Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome. Clin Auton Res (2000) 1.08
Adynamic ileus in severe Guillain-Barré syndrome. Muscle Nerve (2001) 1.07
Hypertrophic Charcot-Marie-Tooth disease. Light and electron microscope studies of the sural nerve. J Neurol Sci (1978) 1.06
Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin Auton Res (1997) 1.05
Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction. Neurogastroenterol Motil (2003) 1.05
Brainstem tumor presenting as an upper gut motility disorder. Gastroenterology (1985) 1.05
Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study. J Neurol Neurosurg Psychiatry (2005) 1.05
Peripheral nerve conduction studies in galactose-poisoned rats. Demonstration of increased resistance to ischemic conduction associated with endoneurial edema due to sugar alcohol accumulation. J Neurol Sci (1983) 1.05
Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve (2005) 1.04
Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci U S A (1991) 1.04